Moneycontrol
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
132.563 0.54 (0.41%)

NAV as on 26 Apr, 2017

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Mar 31, 17)
Equity Sector Value
(Rs cr)
Assets %
Sun Pharma Pharmaceuticals 134.54 15.93
Strides Shasun Pharmaceuticals 80.49 9.53
Aurobindo Pharm Pharmaceuticals 77.02 9.12
Cipla Pharmaceuticals 75.34 8.92
Lupin Pharmaceuticals 70.61 8.36
Glenmark Pharmaceuticals 48.56 5.75
Torrent Pharma Pharmaceuticals 37.92 4.49
Thyrocare Techn Services 35.05 4.15
Natco Pharma Pharmaceuticals 34.54 4.09
Neuland Lab Pharmaceuticals 31.67 3.75
Sector Allocation (Mar 31, 17)
  Sector   % 1-Year
High Low

Pharmaceuticals

89.61 91.18 91.18

Services

6.27 6.06 6.06
Asset Allocation (%) (Mar 31, 17)
Class
%

Equity

95.88

Others / Unlisted

1.16

Debt

0.00

Mutual Funds

N.A

Money Market

3.45

Cash / Call

-0.49

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

51.86

Top 10

74.09
Sectors
%

Top 3

95.88
Sections
Follow us on
Available On